# Efficacy of Seven-day Combined Rabeprazole Plus Levofloxacin Plus Augmentin for Eradication of Helicobacter Pylori

> **NCT01575899** · PHASE4 · TERMINATED · sponsor: **Buddhist Tzu Chi General Hospital** · enrollment: 208 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Levofloxacin-Amox/clav.
- **DRUG:** Clarithromycin-Amoxicillin

## Key facts

- **NCT ID:** NCT01575899
- **Lead sponsor:** Buddhist Tzu Chi General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-12
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 208 (ACTUAL)
- **Why stopped:** Early termination due to efficacy
- **Last updated:** 2012-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01575899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01575899, "Efficacy of Seven-day Combined Rabeprazole Plus Levofloxacin Plus Augmentin for Eradication of Helicobacter Pylori". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01575899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*